The risk for solid tumor development in prior recipients of allogeneic hematopoietic stem cells at the Leukemia/Bone Marrow Transplantation Program of British Columbia was found to be 3.1% at ten years of follow up. Older recipients (40 years and older) and those who received their graft from female donors were particularly susceptible. Extended follow up will be needed to assess more fully the magnitude of second cancers among transplant recipients.Source:
Gallagher G, Forrest DL. Second solid cancers after allogeneic hematopoietic stem cell transplantation. Cancer. 2007;109:84-92.